Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.79
+0.37 (5.76%)
Nov 22, 2024, 4:00 PM EST - Market closed

Company Description

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases.

The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.

It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.

The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.

The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.

Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation
Pulmonx logo
Country United States
Founded 1995
IPO Date Oct 1, 2020
Industry Medical Devices
Sector Healthcare
Employees 279
CEO Steven Williamson

Contact Details

Address:
700 Chesapeake Drive
Redwood City, California 94063
United States
Phone 650 364 0400
Website pulmonx.com

Stock Details

Ticker Symbol LUNG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $19.00
CIK Code 0001127537
CUSIP Number 745848101
ISIN Number US7458481014
SIC Code 3841

Key Executives

Name Position
Steven S. Williamson Chief Executive Officer, President and Director
Geoffrey Beran Rose Chief Commercial Officer
Mehul Joshi Chief Financial Officer
Sri Radhakrishnan Chief Technical Officer
Marcee M. Maroney Vice President of Marketing
Sarah Huber Vice President of Sales (U.S.)
Lisa Paul Chief People Officer
Jérôme Erath Senior Vice President and GM of Europe Middle-East & Africa
John B. McKune Vice President and Corporate Controller

Latest SEC Filings

Date Type Title
Nov 22, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 1, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 17, 2024 144 Filing
Sep 12, 2024 144 Filing
Aug 2, 2024 10-Q Quarterly Report
Jul 31, 2024 8-K Current Report